Simplex Trading
CRMD icon

Simplex Trading’s CorMedix CRMD Stock Holding History

Simplex Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$760K Buy
112,000
+35,500
+46% +$262K ﹤0.01% 2783
2025
Q4 		$890K Sell
76,500
-43,400
-36% -$480K ﹤0.01% 2750
2025
Q3 		$1.39M Buy
119,900
+6,200
+5% +$75K ﹤0.01% 2701
2025
Q2 		$1.4M Sell
113,700
-99,600
-47% -$1.1M ﹤0.01% 2439
2025
Q1 		$1.31M Buy
213,300
+138,400
+185% +$1.43M ﹤0.01% 2443
2024
Q4 		$606K Buy
74,900
+3,800
+5% +$38K ﹤0.01% 3326
2024
Q3 		$574K Buy
71,100
+51,600
+265% +$279K ﹤0.01% 3451
2024
Q2 		$84K Sell
19,500
-12,700
-39% -$64.5K ﹤0.01% 5543
2024
Q1 		$136K Buy
32,200
+21,800
+210% +$75.6K ﹤0.01% 5275
2023
Q4 		$39K Sell
10,400
-17,500
-63% -$60.2K ﹤0.01% 6317
2023
Q3 		$103K Buy
27,900
+3,200
+13% +$12.7K ﹤0.01% 5051
2023
Q2 		$97K Sell
24,700
-3,400
-12% -$16.8K ﹤0.01% 5117
2023
Q1 		$116K Buy
28,100
+23,000
+451% +$94.1K ﹤0.01% 4985
2022
Q4 		$21K Sell
5,100
-5,600
-52% -$19.8K ﹤0.01% 6821
2022
Q3 		$30K Sell
10,700
-10,500
-50% -$43.7K ﹤0.01% 7067
2022
Q2 		$85K Sell
21,200
-9,500
-31% -$35.3K ﹤0.01% 5781
2022
Q1 		$168K Buy
30,700
+20,900
+213% +$95.7K ﹤0.01% 5400
2021
Q4 		$44K Sell
9,800
-40,200
-80% -$200K ﹤0.01% 7420
2021
Q3 		$355K Hold
50,000
– – ﹤0.01% 4641
2021
Q2 		$343K Buy
50,000
+49,631
+13,450% +$395K ﹤0.01% 4750
2021
Q1 		$368K Buy
369
+110
+42% +$1.16K ﹤0.01% 3852
2020
Q4 		$192K Buy
259
+62
+31% +$422 ﹤0.01% 4655
2020
Q3 		$118K Sell
197
-13
-6% -$65 ﹤0.01% 4714
2020
Q2 		$132K Buy
210
+171
+438% +$792 ﹤0.01% 4491
2020
Q1 		$14K Buy
39
+6
+18% +$34 ﹤0.01% 6223
2019
Q4 		$24K Sell
33
-89
-73% -$544 ﹤0.01% 5809
2019
Q3 		$77K Sell
122
-794
-87% -$6.67K ﹤0.01% 4594
2019
Q2 		$821K Sell
916
-596
-39% -$4.68K ﹤0.01% 2084
2019
Q1 		$1.43M Buy
1,512
+1,297
+603% +$11.7K ﹤0.01% 1674
2018
Q4 		$138K Buy
215
+195
+975% +$1.3K ﹤0.01% 3528
2018
Q3 		$9K Buy
+20
New +$49 ﹤0.01% 6456
2016
Q4 		– Sell
-18
Closed -$1K – 5913
2016
Q3 		$1K Buy
18
+4
+29% +$37 ﹤0.01% 5267
2016
Q2 		$1K Buy
+14
New +$213 ﹤0.01% 5242
2015
Q3 		– Sell
-6
Closed -$1K – 5594
2015
Q2 		$1K Buy
6
+5
+500% +$172 ﹤0.01% 4595
2015
Q1 		$1K Buy
+1
New +$24 ﹤0.01% 4430

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's CRMD Position: Q4 2025 in Review

Simplex Trading sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 32,232 shares — an estimated $356K sold.

Simplex Trading first reported a position in CRMD in Q1 2015 and held it in 33 quarters. The position peaked at $1.79M in Q3 2024. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

  • Simplex Trading reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 32,232 CorMedix shares in Q4 2025, an estimated $356K.
  • Simplex Trading first reported a position in CorMedix in Q1 2015 and held it in 33 quarters.
  • Simplex Trading's CorMedix position peaked at $1.79M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.